Breaking News Instant updates and real-time market news.

NRZ

New Residential

$6.78 /

+0.66 (+10.78%)

11:05
05/20/20
05/20
11:05
05/20/20
11:05

New Residential call volume above normal and directionally bullish

Bullish option flow detected in New Residential with 6,643 calls trading, 3x expected, and implied vol increasing over 1 point to 67.11%. Jun-20 7 calls and Jun-20 8 calls are the most active options, with total volume in those strikes near 3,700 contracts. The Put/Call Ratio is 0.14. Earnings are expected on July 30th.

  • 18

    Jun

NRZ New Residential
$6.78 /

+0.66 (+10.78%)

04/08/20 B. Riley FBR
Cherry Hill Mortgage price target lowered to $9 from $15 at B. Riley FBR
04/06/20 Raymond James
Raymond James cuts estimates and targets for residential mortgage REITs
04/02/20 BTIG
New Residential price target lowered to $10.50 from $18 at BTIG
04/02/20 Argus
New Residential downgraded to Hold from Buy at Argus

TODAY'S FREE FLY STORIES

Periodicals
News Corp to cease printing of more than 100 Australian newspapers, WSJ reports » 07:18
05/28/20
05/28
07:18
05/28/20
07:18
NWS

News Corp

$12.30 /

+0.325 (+2.71%)

, NWSA

News Corp.

$12.08 /

+0.19 (+1.60%)

News Corp intends to stop…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NWS News Corp
$12.30 /

+0.325 (+2.71%)

NWSA News Corp.
$12.08 /

+0.19 (+1.60%)

NWS News Corp
$12.30 /

+0.325 (+2.71%)

NWSA News Corp.
$12.08 /

+0.19 (+1.60%)

08/11/19 Credit Suisse
News Corp. upgraded to Outperform from Neutral at Credit Suisse
07/19/19
Fly Intel: Top five analyst downgrades
07/19/19 JPMorgan
JPMorgan downgrades News Corp. to Underweight, cuts price target to $12
07/18/19 JPMorgan
News Corp. downgraded to Underweight from Neutral at JPMorgan
NWS News Corp
$12.30 /

+0.325 (+2.71%)

NWSA News Corp.
$12.08 /

+0.19 (+1.60%)

NWS News Corp
$12.30 /

+0.325 (+2.71%)

NWSA News Corp.
$12.08 /

+0.19 (+1.60%)

NWS News Corp
$12.30 /

+0.325 (+2.71%)

NWSA News Corp.
$12.08 /

+0.19 (+1.60%)

Hot Stocks
Monro: COVID-19 to continue to adversely impact business, results » 07:17
05/28/20
05/28
07:17
05/28/20
07:17
MNRO

Monro

$62.02 /

+1.99 (+3.32%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNRO Monro
$62.02 /

+1.99 (+3.32%)

MNRO Monro
$62.02 /

+1.99 (+3.32%)

04/03/20 SunTrust
Monro price target lowered to $47 from $68 at SunTrust
12/10/19
Fly Intel: Top five analyst upgrades
12/10/19 Guggenheim
Monro upgraded to Buy on store refresh opportunity at Guggenheim
12/10/19 Guggenheim
Monro upgraded to Buy from Neutral at Guggenheim
MNRO Monro
$62.02 /

+1.99 (+3.32%)

Hot Stocks
Seelos Therapeutics initiates preclinical study of SLS-004 » 07:17
05/28/20
05/28
07:17
05/28/20
07:17
SEEL

Seelos Therapeutics

$1.20 /

+0.02 (+1.69%)

Seelos Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEEL Seelos Therapeutics
$1.20 /

+0.02 (+1.69%)

SEEL Seelos Therapeutics
$1.20 /

+0.02 (+1.69%)

11/18/19 H.C. Wainwright
Seelos Therapeutics price target lowered to $2 from $4 at H.C. Wainwright
11/14/19 Benchmark
Seelos Therapeutics initiated with a Speculative Buy at Benchmark
Hot Stocks
Monro delaying annual report on Form 10-K due to COVID-19 disruptions » 07:16
05/28/20
05/28
07:16
05/28/20
07:16
MNRO

Monro

$62.02 /

+1.99 (+3.32%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNRO Monro
$62.02 /

+1.99 (+3.32%)

MNRO Monro
$62.02 /

+1.99 (+3.32%)

04/03/20 SunTrust
Monro price target lowered to $47 from $68 at SunTrust
12/10/19
Fly Intel: Top five analyst upgrades
12/10/19 Guggenheim
Monro upgraded to Buy on store refresh opportunity at Guggenheim
12/10/19 Guggenheim
Monro upgraded to Buy from Neutral at Guggenheim
MNRO Monro
$62.02 /

+1.99 (+3.32%)

Hot Stocks
resTORbio initiates study of RTB101 compared to placebo for COVID-19 prophylaxis » 07:15
05/28/20
05/28
07:15
05/28/20
07:15
TORC

resTORbio

$2.11 /

-0.17 (-7.46%)

resTORbio announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TORC resTORbio
$2.11 /

-0.17 (-7.46%)

TORC resTORbio
$2.11 /

-0.17 (-7.46%)

04/29/20 Evercore ISI
resTORbio upgraded to Outperform from In Line at Evercore ISI
11/15/19 Wedbush
resTORbio downgraded to Neutral from Outperform at Wedbush
11/15/19 Guggenheim
resTORbio downgraded to Neutral from Buy at Guggenheim
11/15/19 Cantor Fitzgerald
resTORbio downgraded to Neutral from Overweight at Cantor Fitzgerald
TORC resTORbio
$2.11 /

-0.17 (-7.46%)

Initiation
GeoPark initiated with a Buy at Stifel » 07:15
05/28/20
05/28
07:15
05/28/20
07:15
GPRK

GeoPark

$7.94 /

+0.12 (+1.53%)

Stifel analyst Robin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPRK GeoPark
$7.94 /

+0.12 (+1.53%)

GPRK GeoPark
$7.94 /

+0.12 (+1.53%)

04/07/20 Scotiabank
GeoPark downgraded to Sector Perform from Outperform at Scotiabank
03/20/20 Eight Capital
GeoPark upgraded to Buy from Neutral at Eight Capital
03/16/20 BMO Capital
GeoPark downgraded to Market Perform from Outperform at BMO Capital
03/02/20 BMO Capital
GeoPark initiated with an Outperform at BMO Capital
GPRK GeoPark
$7.94 /

+0.12 (+1.53%)

Upgrade
Box upgraded to Buy from Hold at Craig-Hallum » 07:14
05/28/20
05/28
07:14
05/28/20
07:14
BOX

Box

$19.64 /

+0.11 (+0.56%)

Craig-Hallum analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOX Box
$19.64 /

+0.11 (+0.56%)

BOX Box
$19.64 /

+0.11 (+0.56%)

03/31/20 Berenberg
Box upgraded to Buy from Hold at Berenberg
03/25/20 Morgan Stanley
Box upgraded to Overweight at Morgan Stanley following 27% pullback
03/25/20 Morgan Stanley
Box upgraded to Overweight from Equal Weight at Morgan Stanley
12/19/19 Gordon Haskett
Dropbox up 8%, Gordon Haskett says could draw 'special situation interest'
BOX Box
$19.64 /

+0.11 (+0.56%)

BOX Box
$19.64 /

+0.11 (+0.56%)

BOX Box
$19.64 /

+0.11 (+0.56%)

Hot Stocks
Moderna study of COVID-19 vaccine now recruiting, clinicaltrials.gov site shows » 07:14
05/28/20
05/28
07:14
05/28/20
07:14
MRNA

Moderna

$52.19 /

-5.54 (-9.60%)

A post, dated May 28, to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$52.19 /

-5.54 (-9.60%)

MRNA Moderna
$52.19 /

-5.54 (-9.60%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/20/20 Morgan Stanley
Moderna price target raised to $90 from $37 at Morgan Stanley
05/19/20 Piper Sandler
Piper trims Moderna target to $100 on capital raise dilution
05/19/20 BMO Capital
Moderna price target raised to $112 from $83 at BMO Capital
MRNA Moderna
$52.19 /

-5.54 (-9.60%)

MRNA Moderna
$52.19 /

-5.54 (-9.60%)

MRNA Moderna
$52.19 /

-5.54 (-9.60%)

MRNA Moderna
$52.19 /

-5.54 (-9.60%)

Hot Stocks
Facebook CEO: People should be able to see what policitians say  07:13
05/28/20
05/28
07:13
05/28/20
07:13
FB

Facebook

$229.17 /

-2.97 (-1.28%)

 
ShowHide Related Items >><<
FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
05/21/20 Stifel
Facebook price target raised to $260 from $245 at Stifel
05/20/20 Deutsche Bank
Facebook Shops could be $30B revenue opportunity, says Deutsche Bank
FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

Hot Stocks
Facebook CEO Zuckerberg: People are going to spend a lot less time commuting  07:13
05/28/20
05/28
07:13
05/28/20
07:13
FB

Facebook

$229.17 /

-2.97 (-1.28%)

 
ShowHide Related Items >><<
FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
05/21/20 Stifel
Facebook price target raised to $260 from $245 at Stifel
05/20/20 Deutsche Bank
Facebook Shops could be $30B revenue opportunity, says Deutsche Bank
FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

Downgrade
Tyson Foods downgraded to Hold from Buy at Argus » 07:12
05/28/20
05/28
07:12
05/28/20
07:12
TSN

Tyson Foods

$62.75 /

+1.2 (+1.95%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$62.75 /

+1.2 (+1.95%)

TSN Tyson Foods
$62.75 /

+1.2 (+1.95%)

05/05/20
Fly Intel: Top five analyst downgrades
05/05/20 JPMorgan
Tyson Foods earnings call not as optimistic as hoped, says JPMorgan
05/05/20 BMO Capital
Tyson Foods price target lowered to $78 from $98 at BMO Capital
05/05/20 BofA
Tyson Foods downgraded to Neutral from Buy at BofA
TSN Tyson Foods
$62.75 /

+1.2 (+1.95%)

TSN Tyson Foods
$62.75 /

+1.2 (+1.95%)

TSN Tyson Foods
$62.75 /

+1.2 (+1.95%)

TSN Tyson Foods
$62.75 /

+1.2 (+1.95%)

Hot Stocks
Apellis initiates Phase 1/2 study of APL-9 in patients with COVID-19 » 07:12
05/28/20
05/28
07:12
05/28/20
07:12
APLS

Apellis

$34.67 /

+0.74 (+2.18%)

Apellis Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLS Apellis
$34.67 /

+0.74 (+2.18%)

APLS Apellis
$34.67 /

+0.74 (+2.18%)

04/28/20 Cantor Fitzgerald
Apellis price target raised to $61 from $54 at Cantor Fitzgerald
04/01/20 Raymond James
Apellis initiated with a Strong Buy at Raymond James
03/31/20 Raymond James
Apellis initiated with a Strong Buy at Raymond James
03/31/20 BMO Capital
Apellis initiated with an Outperform at BMO Capital
APLS Apellis
$34.67 /

+0.74 (+2.18%)

APLS Apellis
$34.67 /

+0.74 (+2.18%)

APLS Apellis
$34.67 /

+0.74 (+2.18%)

Syndicate
Essent Group announces offering of 11M common shares » 07:12
05/28/20
05/28
07:12
05/28/20
07:12
ESNT

Essent Group

$37.46 /

+4.8 (+14.70%)

Goldman Sachs and J.P.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESNT Essent Group
$37.46 /

+4.8 (+14.70%)

ESNT Essent Group
$37.46 /

+4.8 (+14.70%)

05/12/20 Deutsche Bank
Essent Group price target lowered to $47 from $58 at Deutsche Bank
03/26/20 MKM Partners
MKM Partners sees Mortgage Insurers as attractively valued
03/26/20 RBC Capital
Essent Group price target lowered to $36 from $62 at RBC Capital
03/11/20 MKM Partners
Essent Group upgraded to Buy from Neutral at MKM Partners
ESNT Essent Group
$37.46 /

+4.8 (+14.70%)

ESNT Essent Group
$37.46 /

+4.8 (+14.70%)

Hot Stocks
Facebook CEO Zuckerberg: Travel is going to have issues for long time  07:12
05/28/20
05/28
07:12
05/28/20
07:12
FB

Facebook

$229.17 /

-2.97 (-1.28%)

 
ShowHide Related Items >><<
FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
05/21/20 Stifel
Facebook price target raised to $260 from $245 at Stifel
05/20/20 Deutsche Bank
Facebook Shops could be $30B revenue opportunity, says Deutsche Bank
FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

Hot Stocks
Facebook CEO to CNBC: Policiticians can't say whatever they want on Facebook » 07:11
05/28/20
05/28
07:11
05/28/20
07:11
FB

Facebook

$229.17 /

-2.97 (-1.28%)

CEO Mark Zuckerberg is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
05/21/20 Stifel
Facebook price target raised to $260 from $245 at Stifel
05/20/20 Deutsche Bank
Facebook Shops could be $30B revenue opportunity, says Deutsche Bank
FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

FB Facebook
$229.17 /

-2.97 (-1.28%)

Hot Stocks
Dollar General reports Q1 cash flows from operations increased 202.4% to $1.7B  07:11
05/28/20
05/28
07:11
05/28/20
07:11
DG

Dollar General

$186.80 /

+6.41 (+3.55%)

 
ShowHide Related Items >><<
DG Dollar General
$186.80 /

+6.41 (+3.55%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

05/26/20 Deutsche Bank
Dollar General price target raised to $187 from $159 at Deutsche Bank
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar General initiated with a Buy at Goldman Sachs
04/30/20
Fly Intel: Top five analyst downgrades
DG Dollar General
$186.80 /

+6.41 (+3.55%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

DG Dollar General
$186.80 /

+6.41 (+3.55%)

Hot Stocks
Zentalis, Tavros announce platform collaboration for molecule therapies » 07:11
05/28/20
05/28
07:11
05/28/20
07:11
ZNTL

Zentalis

$41.44 /

+2.14 (+5.45%)

Zentalis Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZNTL Zentalis
$41.44 /

+2.14 (+5.45%)

ZNTL Zentalis
$41.44 /

+2.14 (+5.45%)

04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Guggenheim
Guggenheim starts Zentalis at Buy, sees ZN-c5 as potentially best-in-class
04/28/20 Morgan Stanley
Morgan Stanley starts Zentalis at Overweight with $45 price target
04/28/20 SVB Leerink
SVB Leerink bullish on Zentalis, initiates with an Outperform
ZNTL Zentalis
$41.44 /

+2.14 (+5.45%)

ZNTL Zentalis
$41.44 /

+2.14 (+5.45%)

Hot Stocks
Akcea, Ionis announce publication of long-term data of TEGSEDI » 07:10
05/28/20
05/28
07:10
05/28/20
07:10
AKCA

Akcea Therapeutics

$15.03 /

+0.13 (+0.87%)

, IONS

Ionis Pharmaceuticals

$56.08 /

+0.02 (+0.04%)

Akcea Therapeutics (AKCA)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKCA Akcea Therapeutics
$15.03 /

+0.13 (+0.87%)

IONS Ionis Pharmaceuticals
$56.08 /

+0.02 (+0.04%)

AKCA Akcea Therapeutics
$15.03 /

+0.13 (+0.87%)

01/22/20 Stifel
Akcea LICA data look 'solid,' as expected, says Stifel
10/08/19 BMO Capital
Akcea Therapeutics price target lowered to $39 from $43 at BMO Capital
10/07/19 Stifel
Pfizer deal a 'solid, unexpected' win for Akcea Therapeutics, says Stifel
10/07/19
Akcea Therapeutics upgraded to Outperform on Pfizer partnership at Wells Fargo
IONS Ionis Pharmaceuticals
$56.08 /

+0.02 (+0.04%)

05/12/20 RBC Capital
Ionis Pharmaceuticals initiated with an Outperform at RBC Capital
04/22/20 Jefferies
Jefferies remains cautious on Ionis after report from partner Biogen
03/26/20 Cantor Fitzgerald
Ionis Pharmaceuticals price target lowered to $56 from $65 at Cantor Fitzgerald
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
AKCA Akcea Therapeutics
$15.03 /

+0.13 (+0.87%)

IONS Ionis Pharmaceuticals
$56.08 /

+0.02 (+0.04%)

IONS Ionis Pharmaceuticals
$56.08 /

+0.02 (+0.04%)

Hot Stocks
Burlington Stores says sales in re-opened stores have exceeded prior year levels » 07:09
05/28/20
05/28
07:09
05/28/20
07:09
BURL

Burlington Stores

$210.31 /

+1.44 (+0.69%)

All stores were closed by…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

05/11/20 Nomura Instinet
Burlington Stores price target raised to $190 from $170 at Nomura Instinet
03/24/20 Citi
Burlington Stores price target lowered to $205 from $260 at Citi
03/19/20 Nomura Instinet
Burlington Stores price target lowered to $170 from $252 at Nomura Instinet
03/11/20
Fly Intel: Top five analyst upgrades
BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

BURL Burlington Stores
$210.31 /

+1.44 (+0.69%)

Recommendations
Micron price target raised to $70 from $60 at BofA » 07:08
05/28/20
05/28
07:08
05/28/20
07:08
MU

Micron

$49.44 /

+3.65 (+7.97%)

BofA analyst Simon Woo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MU Micron
$49.44 /

+3.65 (+7.97%)

MU Micron
$49.44 /

+3.65 (+7.97%)

06:38 Today Morgan Stanley
Micron Q2 strength is 'reassuring,' but also understood, says Morgan Stanley
05/27/20 KeyBanc
Micron price target raised to $59 from $48 at KeyBanc
05/27/20 Wells Fargo
Micron guidance hike increase Wells' confidence in $7 per share EPS forecast
05/12/20 KeyBanc
Micron sticking with Q3 guidance, says KeyBanc
MU Micron
$49.44 /

+3.65 (+7.97%)

MU Micron
$49.44 /

+3.65 (+7.97%)

MU Micron
$49.44 /

+3.65 (+7.97%)

MU Micron
$49.44 /

+3.65 (+7.97%)

Syndicate
Yeti files to sell 6.07M shares of common stock for holders  07:08
05/28/20
05/28
07:08
05/28/20
07:08
YETI

Yeti

$33.79 /

+1.86 (+5.83%)

 
ShowHide Related Items >><<
YETI Yeti
$33.79 /

+1.86 (+5.83%)

YETI Yeti
$33.79 /

+1.86 (+5.83%)

05/05/20 Piper Sandler
Yeti price target lowered to $34 from $50 at Piper Sandler
04/28/20 BTIG
Yeti initiated with a Buy at BTIG
04/17/20 Stifel
Yeti downgraded to Hold from Buy at Stifel
04/15/20
Fly Intel: Top five analyst downgrades
YETI Yeti
$33.79 /

+1.86 (+5.83%)

YETI Yeti
$33.79 /

+1.86 (+5.83%)

YETI Yeti
$33.79 /

+1.86 (+5.83%)

YETI Yeti
$33.79 /

+1.86 (+5.83%)

Hot Stocks
WindMIL doses first patient in Phase 2 study of MILs in combo w/ nivolumab » 07:07
05/28/20
05/28
07:07
05/28/20
07:07
BMY

Bristol-Myers

$60.39 /

+0.06 (+0.10%)

WindMIL Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

BMY Bristol-Myers
$60.39 /

+0.06 (+0.10%)

Recommendations
Immunomedics CEO change to not impact Trodelvy launch, says H.C. Wainwright » 07:06
05/28/20
05/28
07:06
05/28/20
07:06
IMMU

Immunomedics

$34.18 /

+0.1 (+0.29%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

05:01 Today Piper Sandler
Immunomedics confident in execution despite CEO change, says Piper Sandler
05/06/20 Piper Sandler
Immunomedics well positioned to execute on Trodelvy launch, says Piper Sandler
05/05/20 Barclays
Immunomedics initiated with an Overweight, $40 target at Barclays
05/04/20 Barclays
Immunomedics initiated with an Overweight at Barclays
IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

IMMU Immunomedics
$34.18 /

+0.1 (+0.29%)

Hot Stocks
Dollar Tree up 2.1% after reporting Q1 results  07:05
05/28/20
05/28
07:05
05/28/20
07:05
DLTR

Dollar Tree

$87.43 /

+2.26 (+2.65%)

 
ShowHide Related Items >><<
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

05/26/20 Deutsche Bank
Dollar Tree price target raised to $97 from $87 at Deutsche Bank
05/18/20 Gordon Haskett
Colgate, Dollar Tree speculated as possible Peltz targets by Gordon Haskett
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Dollar Tree initiated with a Buy at Goldman Sachs
DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

DLTR Dollar Tree
$87.43 /

+2.26 (+2.65%)

Hot Stocks
Cerecor announces FDA clearance of IND for CERC-002 » 07:05
05/28/20
05/28
07:05
05/28/20
07:05
CERC

Cerecor

$2.73 /

+0.32 (+13.28%)

Cerecor announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CERC Cerecor
$2.73 /

+0.32 (+13.28%)

CERC Cerecor
$2.73 /

+0.32 (+13.28%)

03/13/20
Fly Intel: Top five analyst downgrades
03/13/20 Maxim
Cerecor downgraded to Hold from Buy at Maxim
01/09/20 Oppenheimer
Cerecor initiated with an Outperform at Oppenheimer
CERC Cerecor
$2.73 /

+0.32 (+13.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.